Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Müller, Kristin M ^a   Tveteraas, Ingun H ^a   Aasrum, Monica ^a   Ødegård, John ^a   Dawood, Mona ^a   Dajani, Olav ^a   Christoffersen, Thoralf ^a   Sandnes, Dagny L ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTENSIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN SHC;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRAIN PANC1; COLON CARCINOGENESIS; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MITOGENESIS; TRANSACTIVATION;

EID: 80053348156     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-421     Document Type: Article

References (67)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007, 7:79-94. 10.1038/nrc2069, 17251915.
3. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol 2007, 213:589-602. 10.1002/jcp.21246, 17786953.
4. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010, 10:181-93. 10.1038/nrc2809, 2898136, 20168319.
5. Neves SR, Ram PT, Iyengar R. G protein pathways. Science 2002, 296:1636-9. 10.1126/science.1071550, 12040175.
6. Riobo NA, Manning DR. Receptors coupled to heterotrimeric G proteins of the G12 family. Trends Pharmacol Sci 2005, 26:146-54. 10.1016/j.tips.2005.01.007, 15749160.
7. Griner EM, Kazanietz MG. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 2007, 7:281-94. 10.1038/nrc2110, 17384583.
8. Gokmen-Polar Y, Murray NR, Velasco MA, Gatalica Z, Fields AP. Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. Cancer Res 2001, 61:1375-81.
9. Graff JR, McNulty AM, Hanna KR, Konicek BW, Lynch RL, Bailey SN, et al. The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 2005, 65:7462-9. 10.1158/0008-5472.CAN-05-0071, 16103100.
10. Evers BM. Neurotensin and growth of normal and neoplastic tissues. Peptides 2006, 27:2424-33. 10.1016/j.peptides.2006.01.028, 16904238.
11. Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 2006, 27:2445-60. 10.1016/j.peptides.2006.04.030, 16887236.
12. Tasuta M, Iishi H, Baba M, Taniguchi H. Enhancement by neurotensin of experimental carcinogenesis induced in rat colon by azoxymethane. Br J Cancer 1990, 62:368-71. 10.1038/bjc.1990.299, 1971434, 2206944.
13. Bugni JM, Al-Rabadi L, Jubbal K, Karagiannides I, Lawson G, Pothoulakis C. The neurotensin receptor-1 promotes tumor development in a sporadic but not an inflammation-associated mouse model of colon cancer. Int J Cancer 2011,
14. Dupouy S, Mourra N, Doan VK, Gompel A, Alifano M, Forgez P. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers. Biochimie 2011, 93:1369-78. 10.1016/j.biochi.2011.04.024, 21605619.
15. Vincent JP, Mazella J, Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol Sci 1999, 20:302-9. 10.1016/S0165-6147(99)01357-7, 10390649.
16. Mazella J, Vincent JP. Functional roles of the NTS2 and NTS3 receptors. Peptides 2006, 27:2469-75. 10.1016/j.peptides.2006.04.026, 16872720.
17. Almeida TA, Rodriguez Y, Hernandez M, Reyes R, Bello AR. Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines. Peptides 2010, 31:242-7. 10.1016/j.peptides.2009.12.007, 20018219.
18. Souaze F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, Bruyneel E, et al. Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. Carcinogenesis 2006, 27:708-16.
19. Wang X, Jackson LN, Johnson SM, Wang Q, Evers BM. Suppression of neurotensin receptor type 1 expression and function by histone deacetylase inhibitors in human colorectal cancers. Mol Cancer Ther 2010, 9:2389-98. 10.1158/1535-7163.MCT-09-1080, 2932703, 20663927.
20. Bossard C, Souaze F, Jarry A, Bezieau S, Mosnier JF, Forgez P, et al. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis. Peptides 2007, 28:2030-5. 10.1016/j.peptides.2007.06.030, 17870207.
21. Gui X, Guzman G, Dobner PR, Kadkol SS. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma. Peptides 2008, 29:1609-15. 10.1016/j.peptides.2008.04.014, 18541341.
22. Maoret JJ, Anini Y, Rouyer-Fessard C, Gully D, Laburthe M. Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer 1999, 80:448-54. 10.1002/(SICI)1097-0215(19990129)80:3<448::AID-IJC19>3.0.CO;2-N, 9935189.
23. Guha S, Lunn JA, Santiskulvong C, Rozengurt E. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Cancer Res 2003, 63:2379-87.
24. Hassan S, Dobner PR, Carraway RE. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. Regul Pept 2004, 120:155-66. 10.1016/j.regpep.2004.03.004, 15177934.
25. Kisfalvi K, Guha S, Rozengurt E. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells. J Cell Physiol 2005, 202:880-90. 10.1002/jcp.20187, 15389644.
26. Guha S, Rey O, Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res 2002, 62:1632-40.
27. Kisfalvi K, Hurd C, Guha S, Rozengurt E. Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells. J Cell Physiol 2010, 223:309-16. 2888293, 20082306.
28. Ehlers RA, Bonnor RM, Wang X, Hellmich MR, Evers BM. Signal transduction mechanisms in neurotensin-mediated cellular regulation. Surgery 1998, 124:239-46. 10.1016/S0039-6060(98)70126-6, 9706144.
29. Wang Q, Zhou Y, Evers BM. Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells. Neoplasia 2006, 8:781-7. 10.1593/neo.06259, 1584301, 16984735.
30. Poinot-Chazel C, Portier M, Bouaboula M, Vita N, Pecceu F, Gully D, et al. Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. Biochem J 1996, 320(Pt 1):145-51. 1217909, 8947479.
31. Wang X, Wang Q, Ives KL, Evers BM. Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells. Clin Cancer Res 2006, 12:5346-55. 10.1158/1078-0432.CCR-06-0968, 2613866, 17000667.
32. Olszewski U, Hamilton G. Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells. Mol Oncol 2009,
33. Olszewski U, Hlozek M, Hamilton G. Activation of Na+/H+ exchanger 1 by neurotensin signaling in pancreatic cancer cell lines. Biochem Biophys Res Commun 2010, 393:414-9. 10.1016/j.bbrc.2010.02.009, 20138826.
34. Refsnes M, Thoresen GH, Dajani OF, Christoffersen T. Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2 alpha: additivity with the effect of norepinephrine, and synergism with epidermal growth factor. J Cell Physiol 1994, 159:35-40. 10.1002/jcp.1041590106, 8138589.
35. Howell GM, Ziober BL, Humphrey LE, Willson JK, Sun L, Lynch M, et al. Regulation of autocrine gastrin expression by the TGF alpha autocrine loop. J Cell Physiol 1995, 162:256-65. 10.1002/jcp.1041620211, 7822434.
36. Mulder KM, Brattain MG. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. Mol Endocrinol 1989, 3:1215-22. 10.1210/mend-3-8-1215, 2674694.
37. Sawhney RS, Zhou GH, Humphrey LE, Ghosh P, Kreisberg JI, Brattain MG. Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. J Biol Chem 2002, 277:75-86.
38. Evers BM, Ishizuka J, Chung DH, Townsend CM, Thompson JC. Neurotensin expression and release in human colon cancers. Ann Surg 1992, 216:423-30. 10.1097/00000658-199210000-00005, 1242644, 1329682.
39. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992, 70:93-104. 10.1016/0092-8674(92)90536-L, 1623525.
40. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 2001, 20:6322-30. 10.1038/sj.onc.1204776, 11607835.
41. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999, 402:884-8.
42. Ohtsu H, Dempsey PJ, Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 2006, 291:C1-10. 10.1152/ajpcell.00620.2005, 16769815.
43. Andreev J, Galisteo ML, Kranenburg O, Logan SK, Chiu ES, Okigaki M, et al. Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J Biol Chem 2001, 276:20130-5. 10.1074/jbc.M102307200, 11274221.
44. Keely SJ, Calandrella SO, Barrett KE. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular ca(2+), PYK-2, and p60(src). J Biol Chem 2000, 275:12619-25. 10.1074/jbc.275.17.12619, 10777553.
45. Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci USA 1990, 87:2466-70. 10.1073/pnas.87.7.2466, 53710, 2138778.
46. Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005, 11:507-14. 10.1038/nm1232, 15834429.
47. Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, et al. The role of transforming growth factor alpha in determining growth factor independence. Cancer Res 2003, 63:4731-8.
48. Howell GM, Humphrey LE, Ziober BL, Awwad R, Periyasamy B, Koterba A, et al. Regulation of transforming growth factor alpha expression in a growth factor-independent cell line. Mol Cell Biol 1998, 18:303-13. 121495, 9418877.
49. Zorbas MA, Yeoman LC. Growth control in a human colon carcinoma cell line mediated by cell-associated transforming growth factor-alpha (TGF alpha). Exp Cell Res 1993, 206:49-57. 10.1006/excr.1993.1119, 8482359.
50. Darmoul D, Gratio V, Devaud H, Laburthe M. Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation. J Biol Chem 2004, 279:20927-34. 10.1074/jbc.M401430200, 15010475.
51. Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2004, 2:514-22.
52. Benistant C, Chapuis H, Roche S. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells. Oncogene 2000, 19:5083-90. 10.1038/sj.onc.1203871, 11042696.
53. Jhawer M, Goel S, Wilson AJ, Montagna C, Ling YH, Byun DS, et al. PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res 2008, 68:1953-61. 10.1158/0008-5472.CAN-07-5659, 18339877.
54. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-7. 10.1126/science.296.5573.1655, 12040186.
55. Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 2008, 415:333-44. 10.1042/BJ20081056, 18842113.
56. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002, 2:489-501. 10.1038/nrc839, 12094235.
57. Di Nicolantonio F, Arena S, Tabernero J, Grosso S, Molinari F, Macarulla T, et al. Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest 2010, 120:2858-66. 10.1172/JCI37539, 2912177, 20664172.
58. Halilovic E, She QB, Ye Q, Pagliarini R, Sellers WR, Solit DB, et al. PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling. Cancer Res 2010, 70:6804-14. 10.1158/0008-5472.CAN-10-0409, 3178450, 20699365.
59. Liu F, Yang P, Baez M, Ni B. Neurotensin negatively modulates Akt activity in neurotensin receptor-1-transfected AV12 cells. J Cell Biochem 2004, 92:603-11. 10.1002/jcb.20098, 15156571.
60. Santiskulvong C, Rozengurt E. Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists. Cell Signal 2007, 19:1348-57. 10.1016/j.cellsig.2007.01.006, 17307332.
61. Liu Y, Su W, Thompson EA, Leitges M, Murray NR, Fields AP. Protein kinase CbetaII regulates its own expression in rat intestinal epithelial cells and the colonic epithelium in vivo. J Biol Chem 2004, 279:45556-63. 10.1074/jbc.M407701200, 15322124.
62. Baba I, Shirasawa S, Iwamoto R, Okumura K, Tsunoda T, Nishioka M, et al. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res 2000, 60:6886-9.
63. Caron RW, Yacoub A, Zhu X, Mitchell C, Han SI, Sasazuki T, et al. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent. Mol Cancer Ther 2005, 4:243-55.
64. Yotsumoto F, Yagi H, Suzuki SO, Oki E, Tsujioka H, Hachisuga T, et al. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun 2008, 365:555-61. 10.1016/j.bbrc.2007.11.015, 18023415.
65. Zhao D, Bakirtzi K, Zhan Y, Zeng H, Koon HW, Pothoulakis C. Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells. J Biol Chem 2011, 286:6092-9. 10.1074/jbc.M110.192534, 21212273.
66. Guillermet-Guibert J, Bjorklof K, Salpekar A, Gonella C, Ramadani F, Bilancio A, et al. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc Natl Acad Sci USA 2008, 105:8292-7. 10.1073/pnas.0707761105, 2448830, 18544649.
67. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 1995, 269:690-3. 10.1126/science.7624799, 7624799.